Chimalakonda, Anjaneya
31  results:
Search for persons X
?
2

Absolute and Relative Bioavailability of Oral Solid Dosage ..:

Chimalakonda, Anjaneya ; Li, Wenying ; Marchisin, David...
Clinical Pharmacology in Drug Development.  12 (2023)  10 - p. 956-965 , 2023
 
?
3

Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibi..:

Jing, Shan ; Lin, Yang ; Dockens, Randy...
Dermatology and Therapy.  13 (2023)  12 - p. 3153-3164 , 2023
 
?
4

Lack of Electrocardiographic Effects of Deucravacitinib in ..:

Chimalakonda, Anjaneya ; Singhal, Shalabh ; Darbenzio, Raymond...
Clinical Pharmacology in Drug Development.  11 (2022)  4 - p. 442-453 , 2022
 
?
5

Pharmacokinetics of 40 kDa Polyethylene glycol (PEG) in mic..:

Sharda, Nidhi ; Khandelwal, Purnima ; Zhang, Lisa...
European Journal of Pharmaceutical Sciences.  165 (2021)  - p. 105928 , 2021
 
?
7

Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Bin..:

Liu, Chunjian ; Lin, James ; Langevine, Charles...
Journal of Medicinal Chemistry.  64 (2020)  1 - p. 677-694 , 2020
 
?
9

Selective Inhibition of Tyrosine Kinase 2 With Deucravaciti..:

Chimalakonda, Anjaneya ; Burke, James ; Cheng, Lihong...
SKIN The Journal of Cutaneous Medicine.  4 (2020)  6 - p. s108 , 2020
 
?
10

Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for..:

Wrobleski, Stephen T. ; Moslin, Ryan ; Lin, Shuqun...
Journal of Medicinal Chemistry.  62 (2019)  20 - p. 8973-8995 , 2019
 
?
11

Pharmacokinetics of 40 kDa PEG in rodents using high-field ..:

Khandelwal, Purnima ; Zhang, Lisa ; Chimalakonda, Anjaneya...
Journal of Pharmaceutical and Biomedical Analysis.  171 (2019)  - p. 30-34 , 2019
 
?
12

Preclinical QSP Modeling in the Pharmaceutical Industry: An..:

Nijsen, Marjoleen J.M.A. ; Wu, Fan ; Bansal, Loveleena...
CPT: Pharmacometrics & Systems Pharmacology.  7 (2018)  3 - p. 135-146 , 2018
 
?
 
?
 
1-15